Epidemiology and risk factors of adverse outcome in nonvariceal upper gastrointestinal bleeding

Tarasov E.E.; Bagin V.A.; Nishnevich E.V.; Astafyeva M.N.; Rudnov V.A.; Prudkov M.I.

doi:https://doi.org/10.17116/hirurgia201905131

Tarasov E.E.

City Clinical Hospital №40, Yekaterinburg, Russian Federation

Bagin V.A.

City Clinical Hospital №40, Yekaterinburg, Russia

Nishnevich E.V.

City Clinical Hospital №40, Yekaterinburg, Russian Federation;
Ural state medical university, Ministry of health of the Russian Federation, Yekaterinburg, Russian Federation

Astafyeva M.N.

City Clinical Hospital №40, Yekaterinburg, Russia

Rudnov V.A.

City Clinical Hospital №40, Yekaterinburg, Russia

Prudkov M.I.

Kafedra fakul'tetskoĭ khirurgii Volgogradskogo gosudarstvennogo meditsinskogo universiteta i kafedra khirurgicheskikh bolezneĭ fakul'teta povysheniia kvalifikatsii i professional'noĭ perepodgotovki Ural'skoĭ gosudarstvennoĭ meditsinskoĭ akademii, Ekaterinburg;
Kafedra fakul'tetskoĭ khirurgii #2 Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Epidemiology and risk factors of adverse outcome in nonvariceal upper gastrointestinal bleeding

Authors:

Tarasov E.E., Bagin V.A., Nishnevich E.V., Astafyeva M.N., Rudnov V.A., Prudkov M.I.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2019;(5): 31‑37

DOI: 10.17116/hirurgia201905131

Read: 2451 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tarasov EE, Bagin VA, Nishnevich EV, Astafyeva MN, Rudnov VA, Prudkov MI. Epidemiology and risk factors of adverse outcome in nonvariceal upper gastrointestinal bleeding. Pirogov Russian Journal of Surgery. 2019;(5):31‑37. (In Russ.)
https://doi.org/10.17116/hirurgia201905131

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Prevalence of postpartum depression in the Russian Federation: a systematic review and meta-analysis. Medical Technologies. Assessment and Choice. 2025;(2):74-87

Contribution of the Russian Academy of Sciences Academician R.G. Oganov to the development of the domestic preventive cardiology. Russian Journal of Preventive Medicine. 2025;(6):7-10

Risk factors for low back pain in healthcare professionals taking care for patients with reduced mobility. Russian Journal of Preventive Medicine. 2025;(7):75-80

Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medicine. 2025;(7):111-118

Ethnic aspects of risk factors for the type 2 diabetes mellitus development in the overweight women of the Pribaikalsky region. Russian Journal of Preventive Medicine. 2025;(8):56-62

Cerebral venous thrombosis in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):11-19

Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cerebrovascular accidents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31

Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97

Symptomatic niches in the uterine scar after cesarean section: analysis of the causes of development and clinical manifestations. Russian Journal of Human Reproduction. 2025;(4):110-115

Features of professional adaptation of doctors beginning their work activities. Russian Journal of Preventive Medicine. 2025;(9):112-118

Abstract:

Aim — to identify risk factors of adverse outcomes in patients with nonvariceal upper gastrointestinal bleeding. Material and methods. Epidemiological observational analytical longitudinal retrospective cohort study included 312 patients who were hospitalized in the Clinical Hospital №40 of Yekaterinburg in 2014—2016. The main inclusion criterion was nonvariceal upper gastrointestinal bleeding. Results. In-hospital mortality was 31 (9.9%) of 312 patients. Multivariate analysis confirmed the following risk factors of mortality: severity of blood loss (OR 22.70, 95% CI 5.08—102.00); open surgery (OR 15.20, 95% CI 2.71—74.80); M. Charlson comorbidity index (OR 2.15, 95% CI 1.34—3.43); risk of recurrent bleeding according to T. Rockall scale (OR 1.76, 95% CI 1.18—2.64). Conclusion. Independent risk factors of adverse outcomes in patients with nonvariceal upper gastrointestinal bleeding are severe hemorrhagic shock, open surgery, high M. Charlson comorbidity index and risk of recurrent bleeding according to T. Rockall scale.

Keywords:

nonvariceal upper gastrointestinal bleeding

gastroduodenal bleeding

J Forrest classification

T Rockall score

M Charlson comorbidity index

risk factors

Authors:

Tarasov E.E.

City Clinical Hospital №40, Yekaterinburg, Russian Federation

Bagin V.A.

City Clinical Hospital №40, Yekaterinburg, Russia

Nishnevich E.V.

City Clinical Hospital №40, Yekaterinburg, Russian Federation;
Ural state medical university, Ministry of health of the Russian Federation, Yekaterinburg, Russian Federation

Astafyeva M.N.

City Clinical Hospital №40, Yekaterinburg, Russia

Rudnov V.A.

City Clinical Hospital №40, Yekaterinburg, Russia

Prudkov M.I.

Close metadata

References:

Kubyshkin VA, Sazhin VP, Fedorov AV, Krivtsov GA, Sazhin IV. Organization and results of surgical care for ulcerative gastroduodenal bleeding in the hospitals of Central Federal District. Khirurgiya. Zhurnal im. N.I. Pirogova. 2017;(2):4-9. (In Russ.) https://doi.org/10.17116/hirurgia201724-9
Targownik LE, Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993—2003. Clin Gastroenterol Hepatol. 2006;4(12):1459-1466. https://doi.org/10.1016/j.cgh.2006.08.018
Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Alimentary pharmacology & therapeutics. 2017;46(9):773-779. https://doi.org/10.1111/apt.14319
Levine M, Beuhler MC, Pizon A, Cantrel FL, Spyres MB, LoVecchio F, Skolnik AB, Brooks D.E. Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications. Ann Emerg Med. 2018;71(3):273-278. https://doi.org/10.1016/j.annemergmed.2017.08.046
Shabunin AV, Nechipay AM, Korzheva IYu, Bedin VV, Bagateliya ZA, Makshiev AE. Prognosis of recurrent ulcer bleeding. Annaly khirurgii. 2016;21(6):363-371. (In Russ.)
Sazhin VP, Savel’ev VM, Sazhin IV, Klimov DE, Sorokin NO. Treatment of patients with a high risk of gastrointestinal bleeding recurrence. Khirurgiya. Zhurnal im. N.I. Pirogova. 2013;(7):20-23. (In Russ.)
Thiebaud PC, Yordanov Y, Galimard JE, Raynal PA, Beaune S, Jacquin L, Ageron FX, Pateron D. and the Initiatives de Recherche aux Urgences Group. Management of upper gastrointestinal bleeding in emergency departments, from bleeding symptoms to diagnosis: a prospective, multicenter, observational study. Scandinavian journal of trauma, resuscitation and emergency meditsine. 2017;25(1):78. https://doi.org/10.1186/s13049-017-0425-6
Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394-397. https://doi.org/10.1016/S0140-6736(74)91770-X
Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316-321. https://doi.org/10.1136/gut.38.3.316
Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318-1321. https://doi.org/10.1016/S0140-6736(00)02816-6
Wang CH, Chen YW, Young YR, Yang CJ, Chen IC. A prospective comparison of 3 scoring systems in upper gastrointestinal bleeding. Am J Emerg Med. 2013;31(5):775-778. https://doi.org/10.1016/j.ajem.2013.01.007
Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P. International consensus recommendations on the management of patients with nonvariceal upper gastro-intestinal bleeding. Ann Intern Med. 2010;152:101-113. https://doi.org/10.7326/0003-4819-152-2-201001190-00009
Evseyev MA, Klishin IM. Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings. The Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010;3:55-62 (In Russ.)
Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. European Journal of Anaesthesiology. 2017;34(6):332-395. https://doi.org/10.1097/EJA.0000000000000630
American College of Surgeons Committee on Trauma. Advanced Trauma Life Support (ATLS) student course manual. 9th ed. Chicago: American College of Surgeons. 2012;69.
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251. https://doi.org/10.1016/0895-4356(94)90129-5
Ermolov AS, Tveritneva LF, Teterin YuS. Modern methods of endoscopic hemostasis in treating ulcerative gastroduodenal hemorrhage (literature review). Medical alphabet. 2017;3(29):41-46. (In Russ.)